Wilmington, Delaware, United States: Uterine cancer is the most common cancer that occurs in the female reproductive system.
Wilmington, Delaware, United States: Uterine cancer is the most common cancer that occurs in the female reproductive system. It is a malignant tumor that starts in the cells of the uterus and can spread to other parts of the body. According to a study by the American Cancer Society (ACS), uterine sarcoma accounts for 5% of the total global uterine cancer cases while endometrial cancer is a more frequent form of uterine cancer.
Read Report Overview - https://www.transparencymarketresearch.com/uterine-cancer-therapies-diagnostic.html
Both these types of cancers can be detected via various medical imaging techniques such as ultrasound and CT scan, magnetic resonance imaging (MRI), and histological examination of the tissues of uterus.
As per the ACS study, cervical cancer is the fifth most fatal cancer in women. The presence of cervical cancer can be checked through endometrial biopsy, colposcopy, or a screening test called a Pap smear. Radiation therapies can also help cure cervical cancer as it is radiosensitive. For the worst cases of infections, surgical removal of the uterus (hysterectomy) is performed. Surgery in combination with radiation therapies is often used to treat endometrial cancer.
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1329
According to the report, the global market for uterine cancer therapies and diagnostic is to expand at a healthy CAGR during the forecast period of 2016 to 2024. The global market for uterine cancer therapies and diagnostic can be segmented on the basis on type of infection, treatment procedures, and major tests. By type, the market can be divided into uterine sarcomas and endometrial carcinomas. By treatment, the market comprises surgery, chemotherapy, immunotherapy, radiation therapy, and follow-up treatment. By major tests, the global market can be split into biopsy, pelvic ultrasound, hysteroscopy, dilation and curettage, and CT scan.
Global Uterine Cancer Therapies and Diagnostic Market: Trends and Opportunities
Awareness about the prevalence of uterine cancer is on the rise among patients as well as healthcare providers, who are now more actively learning about the therapies available for the treatment of these diseases. This is one of the most prominent drivers in the global market for uterine cancer therapies and diagnostic.
Get COVID-19 Analysis on Uterine Cancer Therapies and Diagnostic Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=1329
Additionally, significant increment in healthcare expenditure among the urban population and initiatives by various governments for improving their healthcare infrastructure is fueling the market for uterine cancer therapies and diagnostic. Moreover, technological advancements in healthcare services and the introduction of innovative drugs in regard to uterine cancer is encouraging patients to invest in proper diagnostics and treatments.
Conversely, some of the factors that are likely to curtail the growth of the global market for uterine cancer therapies and diagnostic are the low success rate in clinical trials of cancer drugs, costly treatment procedures, adverse side-effects, and the high toxicity of these drugs.
Make an Enquiry before Buying - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=1329
Global Uterine Cancer Therapies and Diagnostic Market: Region-wise Outlook
According to recent surveys by World Health Organization (WHO), the generality of endometrial cancer is much higher in developed countries such as the U.S. in North America and the U.K. in Europe. This is a result of the changing lifestyles of women in these countries. The prevalence of uterine cancer is more common in women aged 50 years and above. Also, it has been reported that the incidence of cervical cancer is higher in developing countries such as India and China, accounting for 80% of the total incidences.
Companies Mentioned in the Report
Some of the prominent players in the global market for uterine cancer therapies and diagnostic are Abbott Laboratories, Siemens Healthcare Inc., Roche Ltd, and Becton, Dickinson and Company.
More Trending Reports by Transparency Market Research:
Implantable Medical Devices Market: The U.S. implantable medical devices market is predicted to grow, owing to rise in chronic illnesses and improvements in active implanted medical devices.
Prostate Cancer Therapeutics Market: Rise in the prevalence of prostate cancer, launch of promising emerging therapies, & therapeutic biological products, and high growth in hormone-refractory prostate cancer drugs due to lesser side effects are the key factors that are fueling the growth of the global prostate cancer therapeutics market.
Lyophilized Injectable Drugs Market: Rapidly growing contract research manufacturing services (CRAMS) is projected to drive the global lyophilized injectable drugs market.
Osteoarthritis Drugs Market: Rise in awareness regarding degenerative bone diseases in developing countries, and rich pipeline of innovative treatment options are some factors that are expected to boost the global osteoarthritis drugs market during the forecast period.
Head and Neck Cancer Market: The global head and neck cancer market is driven by increase in the patient population, rise in health care infrastructure in developing economies.
Adult Malignant Glioma Therapeutics Market: Gliomas account for more than 70% of all primary brain tumors. Glioblastoma is the most common (65%) and most malignant type of glioma. The global adult malignant glioma therapeutics market is characterized by an unmet medical need of improving survival rates.
Basal Cell Carcinoma Treatment Market: The competitive landscape of the global basal cell carcinoma treatment market is consolidated in nature on account of the presence of a handful of players.
About Us
Transparency Market Research is a global market intelligence company providing market research reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact Us
Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453